Fontolizumab (Huzaf), a humanized anti-IFN-gamma antibody, has clinical activity and excellent tolerability in moderate to severe Crohn’s disease
Titel:
Fontolizumab (Huzaf), a humanized anti-IFN-gamma antibody, has clinical activity and excellent tolerability in moderate to severe Crohn’s disease
Auteur:
Hommes, Daniel Mikhajlova, Tatiana Stoinov, Simeon Stimac, Davor Vucelic, Boris Lonovics, Janos Zakuciova, Maria D’Haens, Geert Van Assche, Gert Pearce, Tillman